Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSTEL III: nifedipine versus atosiban for threatened preterm labour
NL-OMON20652Active, not recruiting
- Sponsor
- AMC Health
- Start
- Jun 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial in Preterm labor (PTL) comparing Nifedipine with Atosiban (2 arms). Primary endpoint: Composite poor neonatal outcome. Started Jun 2011; status: active, not recruiting.
02
Drugs
nifedipineatosiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NL-OMON20652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20652.